Latest

medicine

Featured Neuroscience Open Neuroscience Articles Psychology

·March 31, 2020·4 min read

Depression and anxiety spiked immediately after COVID-19 lockdown announcement

The day following the lockdown of the UK amid the COVID-19 outbreak, 38% of study participants reported significant symptoms of depression, and 36% reported increased levels of anxiety. The day before lockdown, 16% reported depression, and 17% reported feelings of anxiety. The rates of depression and anxiety remained high for a week after the announcement, but not as high as was reported immediately following the lockdown.

Featured Neuroscience Open Neuroscience Articles

·March 31, 2020·2 min read

Individuals taking class of steroid medications at high risk for COVID-19

People who use glucocorticoids, a class of steroids used to treat asthma and arthritis, are at higher risk of developing severe symptoms of COVID-19.

Featured Neuroscience

·March 31, 2020·5 min read

COVID-19 measures may have already averted up to 120,000 deaths across Europe

Implementing strong physical distancing measures across Europe to suppress the spread of COVID-19 has averted over 100,000 deaths, a new model finds.

Featured Neuroscience

·March 30, 2020·5 min read

Using stem cells to combat COVID-19

Transplanting ACE2-mesenchymal stem cells shows promise for the treatment of COVID-19. A small study reveals seven severely ill patients who received the stem cell transplant recovered and were discharged from hospital within 14 days.

This shows a blood test tube with covid19 written on it

Featured Neuroscience

·March 30, 2020·4 min read

FDA approves Houston Methodist for COVID-19 plasma therapy

On Saturday, the FDA approved Houston Methodist to conduct transfused plasma therapy for the treatment of COVID-19. The plasma will be donated from recovered COVID-19 patients and transfused into those critically ill with the virus. Researchers have already begun recruiting donors in the Houston area who have recovered from coronavirus. The first donor was a patient in the Houston Metropolitan area who has been in good health for two weeks following COVID-19 infection.

This shows the virus under different colors representing temperature

Featured Neuroscience

·March 30, 2020·4 min read

Hopes of COVID-19 pandemic respite this spring may depend upon what happens indoors

In addition to physical distancing and improved personal hygiene practices, the seasonal moderation of relative humidity indoors could help slow rates of transmission for COVID-19. However, the virus can still be transmitted via contact and close proximity to those infected, regardless of the season, researchers warn.

Featured Neuroscience

·March 30, 2020·2 min read

COVID-19 patients often infected with other respiratory viruses

Co-infections between COVID-19 and other respiratory infections are more common than previously believed.

This shows covid19 on a computer monitor

Featured Neuroscience

·March 30, 2020·4 min read

Experimental AI tool predicts which COVID-19 patients develop respiratory disease

AI model determined three key features that accurately predict subsequent, severe disease in COVID-19 patients. The three features were levels of the liver enzyme ALT, reported myalgia, and hemoglobin levels. Based on these three factors, the AI was able to determine ARDS risk with 80% accuracy.

This shows a pill with COVID-19 written on it

Featured Neuroscience Open Neuroscience Articles

·March 30, 2020·4 min read

Study identifies which medications are safe to use in COVID-19 treatment

Researchers found no evidence NSAIDs, such as ibuprofen, may result in worse outcomes for some COVID-19 patients or help control the virus. TNF blockers and JAK inhibitors, used to treat inflammation and arthritis, were also found to be safe to use. However, low amounts of prednisolone or tacrolimus therapy may be useful in treating coronavirus infection.

Featured Neuroscience

·March 28, 2020·5 min read

On-again, off-again social distancing might prevent overwhelming hospitals while building immunity to COVID-19

Intermittent social distancing may have to be employed to reduce the burden on the health care system as a result of COVID-19. If COVID-19 is a seasonal ailment, like the flu, a new model shows physical distancing occurring between 25 and 75% of the time would help build up herd immunity and prevent health system overload.

Featured Neuroscience Psychology

·March 28, 2020·7 min read

COVID-19 skeptics and deniers: Why some people stick to deadly beliefs

Despite all of the public health warnings, many people are still ignoring instructions to socially distance during the COVID-19 pandemic. Many influential people are downplaying the severity of the virus, and convincing others that coronavirus is not as serious as health professionals would have us believe. In light of this, researchers discuss why some people stick to their beliefs and act with skepticism, despite overwhelming contradictory evidence.

This shows a man in a surgical mask and covid 19

Featured Neuroscience Open Neuroscience Articles

·March 27, 2020·3 min read

Some COVID-19 patients still have coronavirus after symptoms disappear

Fifty percent of patients treated for mild COVID-19 infections still had the virus up to eight days after symptoms disappeared. Findings suggest patients can remain infectious, even after symptomatic recovery.